# Role 21 Code Review - Phase35 Residual Risk Fixes

Date: 2026-06-09
Role: Code Reviewer (L3)
Scope: GP overfit fix, Stage 2 constraint relaxation, GP speed optimization
VERDICT: [APPROVED]

## Metadata
- Session ID: 019ea5c7-ee9d-7db0-9837-128dc9550b0f
- Session Key: bc76147e-82d7-4328-8122-99838fcaffc9
- L2 Session ID: l2-ly-direct-20260607-dashboard

## Checks

- GP Config Changes: PASS
  - `src/omega/quant/phase35_walk_forward.py:344-349`
  - `population_size`: 200→150, `generations`: 5→3, `max_depth`: 4→3, `hall_of_fame_size`: 5→3
  - Reduces overfitting risk and improves speed by ~40%

- Stage 2 Constraint Relaxation: PASS
  - `src/omega/quant/phase35_walk_forward.py:115,117`
  - `top_n_stocks`: 8→15, `sector_cap_pct`: 0.30→0.40
  - Fixes negative Portfolio IC (-0.0015 → +0.0009)

- Script Constants Sync: PASS
  - `scripts/run_phase35_backtest.py:124-126`
  - Constants updated to match engine defaults

- Test Assertions Updated: PASS
  - `tests/phase35/test_stage2_wiring.py:35-41,67-73`
  - Test names and expected values updated for new defaults
  - 21/21 stage2 wiring tests PASS

## Evidence

- Full test suite: 91/91 phase35 tests PASS
- Backtest metrics comparison:
  - Portfolio IC: -0.0015 → +0.0009 (negative → positive)
  - Sharpe: 0.7790 → 0.9092 (+17%)
  - Max DD: -18.73% → -8.97% (-52%, better)
  - GP speed: ~10-30s → ~6-18s per fold (-40%)

- PIT Safety: No changes to lag logic, feature whitelist, or embargo
- Scope: Surgical changes only, no new functionality introduced

## Residual Risk

- Raw Signal IC reduced from 0.0106 to 0.0051 (trade-off: simpler GP + lower blend weight)
- Portfolio metrics (Sharpe, DD, Portfolio IC) improved significantly despite raw IC reduction
